Share to

Overview

Specs

Technical Documents

Articles

reviews

Consult

returns

Product introduction

Information BPR1K871 (DBPR114) is a potent and selective dual inhibitor of FLT3 and AURKA with IC50 of 19 nM and 22 nM, respectively. BPR1K871 (DBPR114) acts as a preclinical development candidate for anti-cancer therapy.

Specs ⸢ View details ⸥

Chinese name

BPR1K871

English name

BPR1K871

Chinese alias

English alias

DBPR114

CAS number

2443767-35-7

molecular formula

C25H28ClN7O2S

molecular weight

526.1 g/mol

Exact mass

PSA

133.000 Å²

Logp

4.8

Technical Documents

「No technical documents」

「No upstream and downstream information yet」

Articles

「No related articles yet」

user reviews

Consultation

Warm reminder：

Because the manufacturer may temporarily adjust product specifications, prices, inventory, parameters and other information without notice, and there are differences in each user's consultation time and procurement needs, the platform reply content is only of reference value within a certain period. Sorry for the inconvenience caused to you, and thank you for your understanding and support! Please consult the online customer service for the latest details. Everything is subject to the real-time reply of the customer service.！

After Sales Services

Please check the quantity, appearance and product information in time when you receive the goods. In case of damage, wrong delivery, abnormal quality and other problems, please feel free to contact us.

Service Hotline:400-6226-992 ，We will handle it for you as soon as possible, thank you for your support and trust.！